| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;91:2712-2716.)
© 1995 American Heart Association, Inc.
Articles |
From the Alfred and Baker Medical Unit and Cellular Biochemistry Laboratory, Alfred Hospital and Baker Medical Research Institute, Melbourne, Australia.
Correspondence to Dr Anthony Dart, Alfred and Baker Medical Unit, Baker Medical Research Institute, Commercial Rd, Prahran (Melbourne), Victoria 3181, Australia.
Background Reperfusion following myocardial ischemia causes a rapid and transient release of inositol (1,4,5)triphosphate [Ins(1,4,5)P3]. The aim of this study was to test whether this increased Ins(1,4,5)P3 release was important for the development of ventricular arrhythmias and whether agents that inhibit this signal transduction pathway, such as aminoglycoside antibiotics, suppress arrhythmias.
Methods and Results In perfused rat hearts, ventricular tachycardia (VT), ventricular fibrillation (VF), and accumulation of Ins(1,4,5)P3 were measured during early reperfusion. A number of different compounds, including neomycin, gentamicin, streptomycin, spermine, reserpine, and prazosin, were effective in inhibiting the reperfusion-induced Ins(1,4,5)P3 release and the onset of VT and VF in parallel. A strong correlation existed between Ins(1,4,5)P3 content, measured at 2 minutes of reperfusion, and the incidence of reperfusion VT and VF. In addition, intravenous gentamicin suppressed the onset of arrhythmias under ischemic and reperfusion conditions in vivo.
Conclusions Our results are consistent with the view that Ins(1,4,5)P3 release plays a pivotal role in mediating arrhythmias during early reperfusion. Agents inhibiting Ins(1,4,5)P3 release are antiarrhythmic and may have potential use clinically.
Key Words: arrhythmia ischemia reperfusion
This article has been cited by other articles:
![]() |
M. J. Wacker, L. M. Kosloski, W. J. R. Gilbert, C. D. Touchberry, D. S. Moore, J. K. Kelly, M. Brotto, and J. A. Orr Inhibition of Thromboxane A2-Induced Arrhythmias and Intracellular Calcium Changes in Cardiac Myocytes by Blockade of the Inositol Trisphosphate Pathway J. Pharmacol. Exp. Ther., December 1, 2009; 331(3): 917 - 924. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Woodcock, P. M. Kistler, and Y.-K. Ju Phosphoinositide signalling and cardiac arrhythmias Cardiovasc Res, May 1, 2009; 82(2): 286 - 295. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Woodcock, X.-J. Du, M. E. Reichelt, and R. M. Graham Cardiac {alpha}1-adrenergic drive in pathological remodelling Cardiovasc Res, February 1, 2008; 77(3): 452 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Lanzafame, L. Turnbull, F. Amiramahdi, J. F. Arthur, H. Huynh, and E. A. Woodcock Inositol phospholipids localized to caveolae in rat heart are regulated by {alpha}1-adrenergic receptors and by ischemia-reperfusion Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2059 - H2065. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, A. V. Zima, F. Sheikh, L. A. Blatter, and J. Chen Endothelin-1-Induced Arrhythmogenic Ca2+ Signaling Is Abolished in Atrial Myocytes of Inositol-1,4,5-Trisphosphate(IP3)-Receptor Type 2-Deficient Mice Circ. Res., June 24, 2005; 96(12): 1274 - 1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P Headrick, L. Willems, K. J Ashton, K. Holmgren, J. Peart, and G P. Matherne Ischaemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression J. Physiol., June 15, 2003; 549(3): 823 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Woodcock, B. H. Wang, J. F. Arthur, A. Lennard, S. J. Matkovich, X.-J. Du, J. H. Brown, and R. D. Hannan Inositol Polyphosphate 1-Phosphatase Is a Novel Antihypertrophic Factor J. Biol. Chem., June 14, 2002; 277(25): 22734 - 22742. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mackenzie, M. D Bootman, M. Laine, M. J Berridge, J. Thuring, A. Holmes, W.-H. Li, and P. Lipp The role of inositol 1,4,5-trisphosphate receptors in Ca2+ signalling and the generation of arrhythmias in rat atrial myocytes J. Physiol., June 1, 2002; 541(2): 395 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vassort Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium Physiol Rev, April 1, 2001; 81(2): 767 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Duru, M. Barton, T. F. Luscher, and R. Candinas Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? Cardiovasc Res, February 1, 2001; 49(2): 272 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Matkovich and E. A. Woodcock Ca2+-activated but Not G Protein-mediated Inositol Phosphate Responses in Rat Neonatal Cardiomyocytes Involve Inositol 1,4,5-Trisphosphate Generation J. Biol. Chem., April 6, 2000; 275(15): 10845 - 10850. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gysembergh, S. Lemaire, C. Piot, C. Sportouch, S. Richard, R. A. Kloner, and K. Przyklenk Pharmacological manipulation of Ins(1,4,5)P3 signaling mimics preconditioning in rabbit heart Am J Physiol Heart Circ Physiol, December 1, 1999; 277(6): H2458 - H2469. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-J. Du and A. M. Dart Role of sympathoadrenergic mechanisms in arrhythmogenesis Cardiovasc Res, September 1, 1999; 43(4): 832 - 834. [Full Text] [PDF] |
||||
![]() |
E. Carmeliet Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias Physiol Rev, July 1, 1999; 79(3): 917 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kurz, I. Schneider, R. Tolg, and G. Richardt Alpha1-adrenergic receptor-mediated increase in the mass of phosphatidic acid and 1,2-diacylglycerol in ischemic rat heart Cardiovasc Res, April 1, 1999; 42(1): 48 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hatta, R. Maruyama, S. J. Marshall, M. Imamura, and R. Levi Bradykinin Promotes Ischemic Norepinephrine Release in Guinea Pig and Human Hearts J. Pharmacol. Exp. Ther., March 1, 1999; 288(3): 919 - 927. [Abstract] [Full Text] |
||||
![]() |
E. A. Woodcock, N. Reyes, A. N. Jacobsen, and X.-J. Du Inhibition of Inositol(1,4,5)Trisphosphate Generation by Endothelin-1 During Postischemic Reperfusion : A Novel Antiarrhythmic Mechanism Circulation, February 16, 1999; 99(6): 823 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Harrison, D. J. Autelitano, B. H. Wang, C. Milano, X.-J. Du, and E. A. Woodcock Reduced Reperfusion–Induced Ins(1,4,5)P3 Generation and Arrhythmias in Hearts Expressing Constitutively Active {alpha}1B-Adrenergic Receptors Circ. Res., December 14, 1998; 83(12): 1232 - 1240. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A Woodcock, S. J Matkovich, and O. Binah Ins(1,4,5)P3 and cardiac dysfunction Cardiovasc Res, November 1, 1998; 40(2): 251 - 256. [Full Text] [PDF] |
||||
![]() |
M. J Curtis Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation Cardiovasc Res, July 1, 1998; 39(1): 194 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Felzen, M. Shilkrut, H. Less, I. Sarapov, G. Maor, R. Coleman, R. B. Robinson, G. Berke, and O. Binah Fas (CD95/Apo-1)–Mediated Damage to Ventricular Myocytes Induced by Cytotoxic T Lymphocytes From Perforin-Deficient Mice : A Major Role for Inositol 1,4,5-Trisphosphate Circ. Res., March 9, 1998; 82(4): 438 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Watanabe, T. Ishigami, Y. Kawano, T. Umahara, A. Nakamori, S. Mizushima, K. Hibi, I. Kobayashi, K. Tamura, H. Ochiai, et al. Angiotensin-Converting Enzyme Gene I/D Polymorphism and Carotid Plaques in Japanese Hypertension, September 1, 1997; 30(3): 569 - 573. [Abstract] [Full Text] |
||||
![]() |
A. N. Jacobsen, X.-J. Du, K. A. Lambert, A. M. Dart, and E. A. Woodcock Arrhythmogenic Action of Thrombin During Myocardial Reperfusion via Release of Inositol 1,4,5-Triphosphate Circulation, January 1, 1996; 93(1): 23 - 26. [Abstract] [Full Text] |
||||
![]() |
J. F. Arthur, S. J. Matkovich, C. J. Mitchell, T. J. Biden, and E. A. Woodcock Evidence for Selective Coupling of alpha 1-Adrenergic Receptors to Phospholipase C-beta 1 in Rat Neonatal Cardiomyocytes J. Biol. Chem., September 28, 2001; 276(40): 37341 - 37346. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |